National Cancer Institute's Ned Sharpless to be Acting FDA Head - Bloomberg

(Updated - March 12, 2019 12:33 PM EDT)

(Updated - March 12, 2019 12:29 PM EDT)

U.S. Secretary for Health and Human Services Alex Azar announced at a subcommittee hearing that Ned Sharpless, currently director of the National Cancer Institute, will become acting FDA commissioner in early April, according to a report from Bloomberg.

You May Also Be Interested In

• FDA: issues early alert on Abiomed heart pump controller purge cassette issue
• Hunterbrook Capital is short bonds issued by Sammons Financial Group and short Guggenheim Strategic Opportunities Fund
• FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer